Insider · CIK 0002043317
Terry L Evans
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing -, latest -.
Terry L Evans files SEC Form 4 as officer at FENC (FENNEC PHARMACEUTICALS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Terry L Evans has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,687 | 12 d ago |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,519 | 43 d ago |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,351 | Aug 3, 2026 |
| Jun 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,183 | Jul 1, 2026 |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,015 | Jun 1, 2026 |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +168 | $0.00 | $0 | 20,847 | May 1, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +18,456 | $0.00 | $0 | 18,456 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +171 | $0.00 | $0 | 18,627 | Apr 2, 2026 |
| Mar 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +2,052 | $0.00 | $0 | 20,679 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +120,000 | $5.77 | $692k | 270,000 | Apr 2, 2026 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +10,000 | $0.00 | $0 | 10,000 | Apr 3, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +10,000 | $0.00 | $0 | 160,000 | Apr 3, 2025 |
| Nov 13, 2024 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +150,000 | $4.23 | $635k | 150,000 | Nov 13, 2024 |
Questions about Terry L Evans
Answered from the filings on this page, as of the latest one.
Is Terry L Evans buying or selling?
Terry L Evans has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Terry L Evans's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Terry L Evans has 0.
Where does Terry L Evans file Form 4?
Terry L Evans has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.